Retraction Note to: LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice

Retraction Note to: LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice

Bibliographic Details
Main Authors:	Ahsan Habib, Darrell Sawmiller, Song Li, Yang Xiang, David Rongo, Jun Tian, Huayan Hou, Jin Zeng, Adam Smith, Shengnuo Fan, Brian Giunta, Takashi Mori, Glenn Currier, Douglas Ronald Shytle, Jun Tan
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-12-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-021-04444-7

Similar Items

Human Umbilical Cord Blood Serum–derived α-Secretase
by: Ahsan Habib, et al.
Published: (2018-03-01)

Human Umbilical Cord Blood-Derived Monocytes Improve Cognitive Deficits and Reduce Amyloid-β Pathology in PSAPP Mice
by: Donna Darlington, et al.
Published: (2015-11-01)

Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
by: Darrell Sawmiller, et al.
Published: (2017-04-01)

Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
by: She-Qing Zhang, et al.
Published: (2013-01-01)

Propionate and Alzheimer’s Disease
by: Jessica Killingsworth, et al.
Published: (2021-01-01)

Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes
by: Masanari Shiramoto, et al.
Published: (2020-05-01)

Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats
by: Jodie D. Anderson, et al.
Published: (2019-07-01)

Efficacy of insulin lispro in improving glycemic control in gestational diabetes
by: M C Deepaklal, et al.
Published: (2014-01-01)

A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus
by: Marina V. Shestakova, et al.
Published: (2016-07-01)

Case of subcutaneous insulin resistance syndrome treated with ultra‐rapid insulin lispro
by: Takahiro Ishii, et al.
Published: (2022-03-01)

Protocol to Assess the Biological Activity of Insulin Glargine, Insulin Lispro, and Insulin Aspart In Vitro
by: Mamatha Garige, et al.
Published: (2023-03-01)

Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus.
by: Ford-Adams, M, et al.
Published: (2003)

Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
by: Feinglos, M, et al.
Published: (1997)

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
by: Uy J, et al.
Published: (2012-01-01)

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes
by: Dario Giugliano, et al.
Published: (2012-06-01)

Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
by: Giunta Brian, et al.
Published: (2011-06-01)

Long‐term field study of lispro and neutral protamine Hagedorn insulins treatment in dogs with diabetes mellitus
by: Sharon Kuzi, et al.
Published: (2023-03-01)

Valutazione clinica e metabolica dell’impiego dell’insulina Lispro in pazienti con diabete mellito scompensato
by: Antonio Uneddu, et al.
Published: (2005-12-01)

Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis
by: Eleonora Malerba, et al.
Published: (2020-10-01)

Stimulation of cannabinoid receptor 2 (CB<sub>2</sub>) suppresses microglial activation
by: Fernandez Francisco, et al.
Published: (2005-12-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction note
by: Editorial article
Published: (2018-06-01)

Retraction Note
by: S A Malek-Hosseini
Published: (2018-04-01)

Retraction note
Published: (2013-01-01)

Retraction Note
Published: (2020-05-01)

Retraction Note
by: NJMR Editors .
Published: (2014-03-01)

Retraction note
Published: (2018-06-01)

Retraction Note
Published: (2017-09-01)

Retraction note
Published: (2013-07-01)

RETRACTION NOTE
Published: (2016-02-01)

RETRACTION NOTE
by: Biryukova NA.
Published: (2017-03-01)

Retraction note
by: Luisa Acosta Ortega
Published: (2018-02-01)

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature
by: Ajay Kumar
Published: (2016-01-01)